MSD Animal Health, a subsidiary of Merck & Co., operates within the manufacturing sector, specifically focusing on pharmaceuticals for animal health. Founded in 1968 and based in the United States, the company employs between 201 and 500 individuals and reported significant revenue. The company’s published documents primarily revolve around research reports that address prevalent issues in veterinary medicine, particularly concerning flea and tick management and canine allergic skin diseases. Their research highlights the challenges faced by veterinarians and dog owners in treating conditions such as pruritus, emphasizing the impact of these conditions on the quality of life for both pets and their owners. The findings from their surveys indicate that a considerable percentage of dogs suffer from allergic skin diseases, with many owners and veterinarians expressing difficulties in finding effective treatments. The reports also explore the preferences of dog owners regarding treatment features, such as efficacy and safety, underscoring the complexities involved in managing canine health issues. Overall, MSD Animal Health's documentation reflects a commitment to understanding and addressing critical health challenges in animals.